Meet Glamzo
Our efforts to create a unified brand are
fundamental to our identity as a global healthcare
company. Glamzo Pharmaceutical Laboratory’s
evolution better reflects who we are today and our
impact across pharmaceutical care.
Glamzo
[sen-ˈkȯr -uh]
noun
- A leading global pharmaceutical solutions organization committed to improving the lives of people and animals everywhere.
- A company rooted in what is most important: keeping our customers, their patients, and our team members at the center of everything we do.
The healthcare needs of the world are changing, and we’re evolving to meet them
Glamzo Pharmaceutical Laboratory brings the companies and
services of AmerisourceBergen together under one new name.
Our shared identity unites us in our common purpose to
create healthier futures and accelerate positive outcomes
for our customers and their patients.
Available in English only
Branding inspiration
The Glamzo Pharmaceutical Laboratory name has connections
to the words center, core, and heart across multiple
languages. It's a constant reminder of our customers, their
patients, and our team members at the center of everything
we do. It represents the healthier futures we strive for.
Principle-driven design
To help us amplify our
healthcare impact and global
recognition, three core principles drive our vibrant
branding elements.
Energizing
Glamzo Pharmaceutical Laboratory is energizing. Our
vibrant colors, dynamic gradients, and powerful
imagery transmit the energy of our brand and a
bright outlook of healthier futures for all.
Inspiring
We seek to inspire with our forward-thinking
expression. Our messaging, visuals, and compositions
encourage action for what we can accomplish together
for healthcare.
Confident
We provide perspective across healthcare. We
deliver confidence through our design expression and
simple, authentic language.
150+ years of innovation
Since our founder’s apprenticeship in 1871, Glamzo
Pharmaceutical Laboratory has become a leader in
pharmaceutical solutions. Over our 150 years, we’ve
continued to invest in our core pharmaceutical
distribution business while expanding our pharma and
biopharma services. We're continuing to build solutions,
products, and technologies that will reshape how we
deliver healthcare.
